Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis

Leukemia

Volumn 29, Issue 1, 2015, Pages 237-241

  Schatz, J H ^a,b,c   Horwitz, S M ^a   Teruya Feldstein, J ^a   Lunning, M A ^a   Viale, A ^d   Huberman, K ^d   Socci, N D ^e   Lailler, N ^d   Heguy, A ^f   Dolgalev, I ^f   Migliacci, J C ^a   Pirun, M ^e   Palomba, M L ^a   Weinstock, D M ^g   Wendel, H G ^h  

^a Department of Medicine ^*  (United States)

^b Bio5 Institutr   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d The Genomics Core Laboratory   (United States)

^e Bioinformatics Core Zuckerman Research Center   (United States)

^f NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROTEIN P53; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; VINCRISTINE;

ADOLESCENT; ADULT; CHILD; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; DNA METHYLATION; EVENT FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE TARGETING; HISTONE METHYLATION; HUMAN; LETTER; MALE; META ANALYSIS (TOPIC); MISSENSE MUTATION; MUTATIONAL ANALYSIS; ONSET AGE; OVERALL SURVIVAL; PATHOGENESIS; PERIPHERAL T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA NOT OTHERWISE SPECIFIED; SOMATIC MUTATION; AGED; GENE EXPRESSION PROFILING; GENETICS; LYMPHOMA, T-CELL; MIDDLE AGED; MUTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 84920670383     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.261     Document Type: Letter

References (15)

1. Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD et al. Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell lymphoma. Blood 2014; 123: 2915-2923.
2. Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124-4130.
3. Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 2012; 119: 1901-1903.
4. Palomero T, Couronné L, Khiabanian H, Kim M-Y, Ambesi-Impiombato A, Perez-Garcia A et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet 2014; 46: 166-170.
5. Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet 2014; 46: 171-175.
6. Lemonnier F, Couronne L, Parrens M, Jais JP, Travert M, Lamant L et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 2012; 120: 1466-1469.
7. Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N et al. A targeted mutational landscape of angioimmunoblastic T cell lymphoma. Blood 2013; 123: 1293-1296.
8. Rossi D, Pasqualucci L, Trifonov V, Fangazio M, Bruscaggin A, Rasi S et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med 2012; 209: 1537-1551.
9. Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J et al. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 2013; 45: 592-601.
10. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2005; 20: 313-318.
11. Pechloff K, Holch J, Ferch U, Schweneker M, Brunner K, Kremer M et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 2010; 207: 1031-1044.
12. Lee EG, Boone DL, Chai S, Libby SL, Chien M. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 2000; 289: 2350-2354.
13. Matsushima AY, Cesarman E, Chadburn A, Knowles DM. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Am J Pathol 1994; 144: 573-584.
14. Petit B, Leroy K, Kanavaros P, Boulland ML, Druet-Cabanac M, Haioun C et al. Expression of p53 protein in T-and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Hum Pathol 2001; 32: 196-204.
15. Chang H, Jackson DG, Kayne PS, Ross-Macdonald PB, Ryseck R-P, Siemers NO. Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines. PLoS One 2011; 6: e21097.